Eclipse Aesthetics Runs Afoul Of FDA Again For Uncleared Beauty Device
This article was originally published in The Rose Sheet
Executive Summary
Following an October 2015 warning letter for marketing an FDA-cleared medical device for unapproved cosmetic indications, Eclipse is targeted for marketing its MicroPen Elite micro-needling device as a safe alternative to other skin-resurfacing techniques without required premarket authorization.
You may also be interested in...
FDA: Cosmetic Warning Letters Carry Same Weight Regardless Of Issuing Office
Around 96% of warning letters for excessive cosmetics claims in 2016 have issued from FDA district offices as opposed to CFSAN headquarters, representing a marked shift from previous years. The agency stresses, however, that the source of a warning letter has no bearing on its implications.
Skarp Laser Razor’s Journey To Market Not Quite Light Speed
Skarp Technologies, which has more than a half-million investor dollars riding on its laser razor, has pushed back its delivery target for the second time to end of 2016, while acknowledging that 2017 may be more realistic. The firm says it’s making “great strides” in the laser and optical fiber’s development, which may resolve weaknesses observed in prototype demos to date, but plenty of questions about the project remain.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.